Hsbc Holdings PLC Cytokinetics Inc Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $406,665 - $505,364	13,804 New	13,804 $406,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $634,345 - $906,384	17,734 New	17,734 $812,000
Q2 2022 Aug 11, 2022	SELL	$33.93 - $48.92 $660,684 - $952,570	-19,472 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $405,623 - $627,394	13,639 Added 233.82%	19,472 $727,000
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $200,363 - $270,534	5,833 New	5,833 $265,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.